Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Christopher Raymond's Stock Ratings
Piper Sandler Analyst
Christopher Raymond is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/01/2025
Overall Average Return
1.86%
Smart Score
Overall Average Return Percentile
47th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/29/2025 | BIIB | Buy Now | Biogen | $121.67 | -5.48% | Christopher Raymond60% | $135 → $115 | Maintains | Neutral | Get Alert |
| 03/06/2025 | ALXO | Buy Now | ALX Oncology Holdings | $0.52 | 1639.13% | Christopher Raymond60% | $8 → $9 | Maintains | Overweight | Get Alert |
| 02/20/2025 | BMRN | Buy Now | Biomarin Pharmaceutical | $63.13 | 99.59% | Christopher Raymond60% | $122 → $126 | Maintains | Overweight | Get Alert |
| 02/18/2025 | BIIB | Buy Now | Biogen | $121.67 | 10.96% | Christopher Raymond60% | $138 → $135 | Reiterates | Neutral → Neutral | Get Alert |
| 02/11/2025 | QTTB | Buy Now | Q32 Bio | $1.52 | 163.16% | Christopher Raymond60% | $20 → $4 | Downgrade | Overweight → Neutral | Get Alert |
| 01/27/2025 | ARDX | Buy Now | Ardelyx | $5.55 | 44.04% | Christopher Raymond60% | $7 → $8 | Maintains | Neutral | Get Alert |
| 01/27/2025 | BPMC | Buy Now | Blueprint Medicines | $98.06 | 21.36% | Christopher Raymond60% | $109 → $119 | Maintains | Neutral | Get Alert |
| 01/27/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | 6.22% | Christopher Raymond60% | $535 → $533 | Maintains | Overweight | Get Alert |
| 01/27/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $583.98 | 73.46% | Christopher Raymond60% | $1195 → $1013 | Maintains | Overweight | Get Alert |
| 01/13/2025 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.81 | 260.73% | Christopher Raymond60% | $135 → $140 | Maintains | Overweight | Get Alert |
| 01/13/2025 | INZY | Buy Now | Inozyme Pharma | $1.20 | 2410.46% | Christopher Raymond60% | $43 → $30 | Maintains | Overweight | Get Alert |
| 01/10/2025 | MNPR | Buy Now | Monopar Therapeutics | $43.29 | 66.33% | Christopher Raymond60% | → $72 | Initiates | → Overweight | Get Alert |
| 01/02/2025 | BIIB | Buy Now | Biogen | $121.67 | 13.43% | Christopher Raymond60% | $315 → $138 | Downgrade | Overweight → Neutral | Get Alert |
| 12/17/2024 | ABBV | Buy Now | AbbVie | $194.54 | 13.08% | Christopher Raymond60% | $212 → $220 | Maintains | Overweight | Get Alert |
| 12/11/2024 | QTTB | Buy Now | Q32 Bio | $1.52 | 1215.79% | Christopher Raymond60% | $85 → $20 | Maintains | Overweight | Get Alert |
| 11/18/2024 | ACRS | Buy Now | Aclaris Therapeutics | $1.37 | 848.91% | Christopher Raymond60% | $3 → $13 | Upgrade | Neutral → Overweight | Get Alert |
| 11/06/2024 | KPTI | Buy Now | Karyopharm Therapeutics | $6.85 | -27.01% | Christopher Raymond60% | $60 → $75 | Maintains | Overweight | Get Alert |
| 11/01/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $583.98 | 104.63% | Christopher Raymond60% | $1242 → $1195 | Maintains | Overweight | Get Alert |
| 09/23/2024 | BHVN | Buy Now | Biohaven | $22.50 | 237.78% | Christopher Raymond60% | $66 → $76 | Maintains | Overweight | Get Alert |
| 09/05/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $63.13 | 93.25% | Christopher Raymond60% | $107 → $122 | Maintains | Overweight | Get Alert |
| 09/03/2024 | IOBT | Buy Now | IO Biotech | $1.02 | 880.39% | Christopher Raymond60% | $10 → $10 | Maintains | Overweight | Get Alert |
| 08/27/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $63.13 | 69.49% | Christopher Raymond60% | $107 → $107 | Maintains | Overweight | Get Alert |
| 08/23/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $583.98 | 112.68% | Christopher Raymond60% | $1166 → $1242 | Maintains | Overweight | Get Alert |
| 08/23/2024 | ABBV | Buy Now | AbbVie | $194.54 | 7.43% | Christopher Raymond60% | $196 → $209 | Maintains | Overweight | Get Alert |
| 08/15/2024 | TYRA | Buy Now | Tyra Biosciences | $10.34 | 219.15% | Christopher Raymond60% | → $33 | Initiates | → Overweight | Get Alert |
| 08/02/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | 6.62% | Christopher Raymond60% | $500 → $535 | Maintains | Overweight | Get Alert |
| 07/19/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $583.98 | 99.66% | Christopher Raymond60% | $1000 → $1166 | Maintains | Overweight | Get Alert |
| 07/12/2024 | BIIB | Buy Now | Biogen | $121.67 | 157.26% | Christopher Raymond60% | $335 → $313 | Maintains | Overweight | Get Alert |
| 07/02/2024 | ABBV | Buy Now | AbbVie | $194.54 | -2.34% | Christopher Raymond60% | $190 → $190 | Maintains | Overweight | Get Alert |
| 07/01/2024 | TSHA | Buy Now | Taysha Gene Therapies | $2.33 | 201.08% | Christopher Raymond60% | $9 → $7 | Maintains | Overweight | Get Alert |
| 06/18/2024 | ABBV | Buy Now | AbbVie | $194.54 | -2.34% | Christopher Raymond60% | $185 → $190 | Maintains | Overweight | Get Alert |
| 05/24/2024 | ARDX | Buy Now | Ardelyx | $5.55 | 170.08% | Christopher Raymond60% | $15 → $15 | Maintains | Overweight | Get Alert |
| 05/07/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -9.13% | Christopher Raymond60% | $450 → $456 | Maintains | Overweight | Get Alert |
| 05/03/2024 | BPMC | Buy Now | Blueprint Medicines | $98.06 | 6.06% | Christopher Raymond60% | $78 → $104 | Maintains | Neutral | Get Alert |
| 04/29/2024 | ABVX | Buy Now | Abivax | $6.82 | 516.29% | Christopher Raymond60% | → $42 | Initiates | → Overweight | Get Alert |
| 04/09/2024 | TSHA | Buy Now | Taysha Gene Therapies | $2.33 | 287.1% | Christopher Raymond60% | → $9 | Initiates | → Overweight | Get Alert |
| 04/02/2024 | QTTB | Buy Now | Q32 Bio | $1.52 | 2860.53% | Christopher Raymond60% | → $45 | Initiates | → Overweight | Get Alert |
| 03/08/2024 | ALXO | Buy Now | ALX Oncology Holdings | $0.52 | 3957.97% | Christopher Raymond60% | $11 → $21 | Maintains | Overweight | Get Alert |
| 02/23/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $63.13 | 69.49% | Christopher Raymond60% | $115 → $107 | Maintains | Overweight | Get Alert |
| 02/23/2024 | ARDX | Buy Now | Ardelyx | $5.55 | 170.08% | Christopher Raymond60% | $12 → $15 | Maintains | Overweight | Get Alert |
| 02/14/2024 | BIIB | Buy Now | Biogen | $121.67 | 167.13% | Christopher Raymond60% | $350 → $325 | Maintains | Overweight | Get Alert |
| 12/22/2023 | ALVR | Buy Now | AlloVir | — | — | Christopher Raymond60% | $621 → $34.5 | Downgrade | Overweight → Neutral | Get Alert |
| 11/15/2023 | BHVN | Buy Now | Biohaven | $22.50 | 60% | Christopher Raymond60% | $29 → $36 | Maintains | Overweight | Get Alert |
| 11/03/2023 | KPTI | Buy Now | Karyopharm Therapeutics | $6.85 | -27.01% | Christopher Raymond60% | $105 → $75 | Maintains | Overweight | Get Alert |
| 11/03/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $583.98 | 53.26% | Christopher Raymond60% | $885 → $895 | Maintains | Overweight | Get Alert |
| 11/02/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $63.13 | 82.16% | Christopher Raymond60% | $125 → $115 | Maintains | Overweight | Get Alert |
| 10/30/2023 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Christopher Raymond60% | $18 → $23 | Upgrade | Neutral → Overweight | Get Alert |
| 10/25/2023 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.81 | 234.97% | Christopher Raymond60% | $135 → $130 | Maintains | Overweight | Get Alert |
| 10/11/2023 | ALXO | Buy Now | ALX Oncology Holdings | $0.52 | 2025.6% | Christopher Raymond60% | $8 → $11 | Maintains | Overweight | Get Alert |
| 09/28/2023 | IOBT | Buy Now | IO Biotech | $1.02 | 880.39% | Christopher Raymond60% | → $10 | Initiates | → Overweight | Get Alert |
| 09/19/2023 | KNTE | Buy Now | Kinnate Biopharma | — | — | Christopher Raymond60% | $20 → $4 | Downgrade | Overweight → Neutral | Get Alert |
| 08/11/2023 | ALXO | Buy Now | ALX Oncology Holdings | $0.52 | 1445.89% | Christopher Raymond60% | $48 → $8 | Maintains | Overweight | Get Alert |
| 08/03/2023 | KPTI | Buy Now | Karyopharm Therapeutics | $6.85 | 2.19% | Christopher Raymond60% | $120 → $105 | Maintains | Overweight | Get Alert |
| 07/28/2023 | ABBV | Buy Now | AbbVie | $194.54 | -12.62% | Christopher Raymond60% | $163 → $170 | Maintains | Overweight | Get Alert |
| 06/12/2023 | COGT | Buy Now | Cogent Biosciences | $5.38 | 308.92% | Christopher Raymond60% | → $22 | Maintains | Overweight | Get Alert |
| 06/01/2023 | BIIB | Buy Now | Biogen | $121.67 | 195.89% | Christopher Raymond60% | $346 → $360 | Maintains | Overweight | Get Alert |
| 05/31/2023 | AKBA | Buy Now | Akebia Therapeutics | $2.42 | 65.29% | Christopher Raymond60% | $2 → $4 | Upgrade | Neutral → Overweight | Get Alert |
| 05/23/2023 | VECT | Buy Now | VectivBio Holding | — | — | Christopher Raymond60% | $25 → $17 | Downgrade | Overweight → Neutral | Get Alert |
| 05/12/2023 | MGTX | Buy Now | MeiraGTx Hldgs | $7.16 | 249.41% | Christopher Raymond60% | $26 → $25 | Maintains | Overweight | Get Alert |
| 05/04/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -23.28% | Christopher Raymond60% | → $385 | Assumes | → Overweight | Get Alert |
| 04/28/2023 | AMGN | Buy Now | Amgen | $284.62 | 1.19% | Christopher Raymond60% | $293 → $288 | Maintains | Overweight | Get Alert |
| 04/27/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $63.13 | 98% | Christopher Raymond60% | $128 → $125 | Maintains | Overweight | Get Alert |
| 04/17/2023 | BIIB | Buy Now | Biogen | $121.67 | 184.39% | Christopher Raymond60% | $280 → $346 | Upgrade | Neutral → Overweight | Get Alert |
| 02/10/2023 | ABBV | Buy Now | AbbVie | $194.54 | -16.21% | Christopher Raymond60% | $157 → $163 | Maintains | Overweight | Get Alert |
| 02/03/2023 | AGIO | Buy Now | Agios Pharmaceuticals | $30.19 | 35.81% | Christopher Raymond60% | → $41 | Initiates | → Overweight | Get Alert |
| 01/19/2023 | AMGN | Buy Now | Amgen | $284.62 | 2.94% | Christopher Raymond60% | $299 → $293 | Maintains | Overweight | Get Alert |
| 01/19/2023 | KPTI | Buy Now | Karyopharm Therapeutics | $6.85 | 16.79% | Christopher Raymond60% | → $120 | Initiates | → Overweight | Get Alert |
| 01/17/2023 | ABBV | Buy Now | AbbVie | $194.54 | -19.3% | Christopher Raymond60% | $155 → $157 | Maintains | Overweight | Get Alert |
| 12/13/2022 | AMGN | Buy Now | Amgen | $284.62 | 5.05% | Christopher Raymond60% | $297 → $299 | Maintains | Overweight | Get Alert |
| 11/17/2022 | ARDX | Buy Now | Ardelyx | $5.55 | 44.04% | Christopher Raymond60% | $3 → $8 | Upgrade | Neutral → Overweight | Get Alert |
| 11/04/2022 | AMGN | Buy Now | Amgen | $284.62 | -2.33% | Christopher Raymond60% | $265 → $278 | Maintains | Overweight | Get Alert |
| 11/04/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $583.98 | 31% | Christopher Raymond60% | $775 → $765 | Maintains | Overweight | Get Alert |
| 10/26/2022 | BHVN | Buy Now | Biohaven | $22.50 | -6.67% | Christopher Raymond60% | $23 → $21 | Maintains | Overweight | Get Alert |
| 10/13/2022 | OTIC | Buy Now | Otonomy | — | — | Christopher Raymond60% | $3 → $0.5 | Downgrade | Overweight → Neutral | Get Alert |
| 10/12/2022 | BHVN | Buy Now | Biohaven | $22.50 | 2.22% | Christopher Raymond60% | → $23 | Initiates | → Overweight | Get Alert |
| 09/28/2022 | BIIB | Buy Now | Biogen | $121.67 | 130.14% | Christopher Raymond60% | $200 → $280 | Maintains | Neutral | Get Alert |
| 09/13/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $583.98 | 32.71% | Christopher Raymond60% | $692 → $775 | Maintains | Overweight | Get Alert |
| 08/19/2022 | BHVN | Buy Now | Biohaven | $22.50 | — | Christopher Raymond60% | — | Downgrade | Overweight → Neutral | Get Alert |
| 08/12/2022 | APTX | Buy Now | Aptinyx | — | — | Christopher Raymond60% | $6 → $2 | Downgrade | Overweight → Neutral | Get Alert |
| 08/09/2022 | BMRN | Buy Now | Biomarin Pharmaceutical | $63.13 | 102.76% | Christopher Raymond60% | $125 → $128 | Maintains | Overweight | Get Alert |
| 08/05/2022 | AMGN | Buy Now | Amgen | $284.62 | -6.89% | Christopher Raymond60% | $260 → $265 | Maintains | Overweight | Get Alert |
| 08/01/2022 | ABBV | Buy Now | AbbVie | $194.54 | -20.33% | Christopher Raymond60% | $160 → $155 | Maintains | Overweight | Get Alert |
| 07/29/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.81 | 234.97% | Christopher Raymond60% | $135 → $130 | Maintains | Overweight | Get Alert |
| 07/26/2022 | ONON | Buy Now | On Holding | $48.61 | -42.4% | Christopher Raymond60% | → $28 | Initiates | → Overweight | Get Alert |
| 07/01/2022 | VECT | Buy Now | VectivBio Holding | — | — | Christopher Raymond60% | → $23 | Initiates | → Overweight | Get Alert |
| 05/19/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.81 | 247.85% | Christopher Raymond60% | $170 → $135 | Maintains | Overweight | Get Alert |
| 05/19/2022 | ONCR | Buy Now | Oncorus | — | — | Christopher Raymond60% | $40 → $12 | Maintains | Overweight | Get Alert |
| 05/19/2022 | KNTE | Buy Now | Kinnate Biopharma | — | — | Christopher Raymond60% | $52 → $30 | Maintains | Overweight | Get Alert |
| 05/19/2022 | GRAY | Buy Now | Graybug Vision | — | — | Christopher Raymond60% | $56 → $28 | Maintains | Neutral | Get Alert |
| 05/19/2022 | BPMC | Buy Now | Blueprint Medicines | $98.06 | -33.71% | Christopher Raymond60% | $84 → $65 | Maintains | Neutral | Get Alert |
| 05/19/2022 | ARDX | Buy Now | Ardelyx | $5.55 | -45.98% | Christopher Raymond60% | $4 → $3 | Maintains | Neutral | Get Alert |
| 05/19/2022 | APTX | Buy Now | Aptinyx | — | — | Christopher Raymond60% | $10 → $6 | Maintains | Overweight | Get Alert |
| 05/19/2022 | ALXO | Buy Now | ALX Oncology Holdings | $0.52 | 9175.36% | Christopher Raymond60% | $70 → $48 | Maintains | Overweight | Get Alert |
| 05/19/2022 | ALVR | Buy Now | AlloVir | — | — | Christopher Raymond60% | $1265 → $782 | Maintains | Overweight | Get Alert |
| 04/28/2022 | AMGN | Buy Now | Amgen | $284.62 | -8.65% | Christopher Raymond60% | $255 → $260 | Maintains | Overweight | Get Alert |
| 03/31/2022 | AKBA | Buy Now | Akebia Therapeutics | $2.42 | -17.36% | Christopher Raymond60% | $8 → $2 | Downgrade | Overweight → Neutral | Get Alert |
| 02/24/2022 | BMRN | Buy Now | Biomarin Pharmaceutical | $63.13 | 98% | Christopher Raymond60% | $121 → $125 | Maintains | Overweight | Get Alert |
| 01/18/2022 | ABBV | Buy Now | AbbVie | $194.54 | -17.76% | Christopher Raymond60% | → $160 | Reiterates | → Overweight | Get Alert |
| 01/12/2022 | BIIB | Buy Now | Biogen | $121.67 | 77.54% | Christopher Raymond60% | $362 → $216 | Downgrade | Overweight → Neutral | Get Alert |
| 01/03/2022 | ABBV | Buy Now | AbbVie | $194.54 | -17.76% | Christopher Raymond60% | $129 → $160 | Maintains | Overweight | Get Alert |
| 11/01/2021 | ABBV | Buy Now | AbbVie | $194.54 | -33.69% | Christopher Raymond60% | $124 → $129 | Maintains | Overweight | Get Alert |
| 10/05/2021 | BHVN | Buy Now | Biohaven | $22.50 | 593.33% | Christopher Raymond60% | $140 → $156 | Maintains | Overweight | Get Alert |
| 09/30/2021 | XLRN | Buy Now | Acceleron Pharma | — | — | Christopher Raymond60% | $146 → $180 | Downgrade | Overweight → Neutral | Get Alert |
| 08/23/2021 | NUVL | Buy Now | Nuvalent | $77.07 | -48.1% | Christopher Raymond60% | → $40 | Initiates | → Overweight | Get Alert |
| 07/20/2021 | ARDX | Buy Now | Ardelyx | $5.55 | -27.98% | Christopher Raymond60% | $14 → $4 | Downgrade | Overweight → Neutral | Get Alert |
| 07/12/2021 | SLDB | Buy Now | Solid Biosciences | $3.58 | 67.6% | Christopher Raymond60% | → $90 | Initiates | → Neutral | Get Alert |
| 06/18/2021 | BIIB | Buy Now | Biogen | $121.67 | 269.87% | Christopher Raymond60% | $384 → $450 | Upgrade | Neutral → Overweight | Get Alert |
| 06/15/2021 | ACRS | Buy Now | Aclaris Therapeutics | $1.37 | 2089.78% | Christopher Raymond60% | → $30 | Initiates | → Overweight | Get Alert |
| 03/09/2021 | GRAY | Buy Now | Graybug Vision | — | — | Christopher Raymond60% | $378 → $140 | Downgrade | Overweight → Neutral | Get Alert |
| 02/26/2021 | XLRN | Buy Now | Acceleron Pharma | — | — | Christopher Raymond60% | $130 → $143 | Maintains | Overweight | Get Alert |
| 02/12/2021 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.81 | 338.03% | Christopher Raymond60% | $165 → $170 | Maintains | Overweight | Get Alert |
| 02/03/2021 | AMGN | Buy Now | Amgen | $284.62 | -8.65% | Christopher Raymond60% | $280 → $260 | Maintains | Overweight | Get Alert |
| 12/28/2020 | KNTE | Buy Now | Kinnate Biopharma | — | — | Christopher Raymond60% | → $60 | Initiates | → Overweight | Get Alert |
| 10/27/2020 | ONCR | Buy Now | Oncorus | — | — | Christopher Raymond60% | → $40 | Initiates | → Overweight | Get Alert |
| 10/27/2020 | APTX | Buy Now | Aptinyx | — | — | Christopher Raymond60% | → $10 | Initiates | → Overweight | Get Alert |
| 10/20/2020 | GRAY | Buy Now | Graybug Vision | — | — | Christopher Raymond60% | → $378 | Initiates | → Overweight | Get Alert |
| 10/20/2020 | GRAY | Buy Now | Graybug Vision | — | — | Christopher Raymond60% | → $378 | Initiates | → Overweight | Get Alert |
| 10/20/2020 | BIIB | Buy Now | Biogen | $121.67 | 117.81% | Christopher Raymond60% | $270 → $265 | Maintains | Neutral | Get Alert |
| 10/01/2020 | AMAG | Buy Now | AMAG Pharmaceuticals | — | — | Christopher Raymond60% | — | Upgrade | Underweight → Neutral | Get Alert |
| 08/31/2020 | AIMT | Buy Now | Aimmune Therapeutics | — | — | Christopher Raymond60% | $60 → $34.5 | Downgrade | Overweight → Neutral | Get Alert |
| 08/11/2020 | ALXO | Buy Now | ALX Oncology Holdings | $0.52 | 10528.02% | Christopher Raymond60% | → $55 | Initiates | → Overweight | Get Alert |
| 07/29/2020 | AMGN | Buy Now | Amgen | $284.62 | -5.14% | Christopher Raymond60% | $255 → $270 | Maintains | Overweight | Get Alert |
| 04/09/2020 | PRVL | Buy Now | Prevail Therapeutics | — | — | Christopher Raymond60% | → $20 | Initiates | → Overweight | Get Alert |
| 03/13/2020 | INO | Buy Now | Inovio Pharmaceuticals | $1.86 | 328.95% | Christopher Raymond60% | → $96 | Downgrade | Overweight → Neutral | Get Alert |
| 01/03/2020 | INO | Buy Now | Inovio Pharmaceuticals | $1.86 | 328.95% | Christopher Raymond60% | $120 → $96 | Maintains | Overweight | Get Alert |
| 10/30/2019 | AMAG | Buy Now | AMAG Pharmaceuticals | — | — | Christopher Raymond60% | $9 → $6 | Downgrade | Neutral → Underweight | Get Alert |
| 08/29/2019 | BPMC | Buy Now | Blueprint Medicines | $98.06 | -13.31% | Christopher Raymond60% | → $85 | Initiates | → Neutral | Get Alert |
| 06/28/2019 | BIIB | Buy Now | Biogen | $121.67 | 105.48% | Christopher Raymond60% | $280 → $250 | Downgrade | Overweight → Neutral | Get Alert |
| 05/08/2019 | BHVN | Buy Now | Biohaven | $22.50 | 344.44% | Christopher Raymond60% | $75 → $100 | Maintains | Overweight | Get Alert |
| 04/08/2019 | ARDX | Buy Now | Ardelyx | $5.55 | — | Christopher Raymond60% | — | Initiates | → Overweight | Get Alert |
| 01/02/2019 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | — | Christopher Raymond60% | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 10/25/2018 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -59.94% | Christopher Raymond60% | $211 → $201 | Maintains | Outperform | Get Alert |
| 07/27/2018 | AMGN | Buy Now | Amgen | $284.62 | -26.22% | Christopher Raymond60% | $190 → $210 | Maintains | Overweight | Get Alert |
| 02/02/2018 | AMGN | Buy Now | Amgen | $284.62 | -33.24% | Christopher Raymond60% | $194 → $190 | Maintains | Overweight | Get Alert |
| 12/18/2017 | AKBA | Buy Now | Akebia Therapeutics | $2.42 | 974.38% | Christopher Raymond60% | → $26 | Initiates | → Overweight | Get Alert |
| 10/23/2017 | AMAG | Buy Now | AMAG Pharmaceuticals | — | — | Christopher Raymond60% | → $18 | Initiates | → Neutral | Get Alert |
| 10/23/2017 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Christopher Raymond60% | → $170 | Assumes | Overweight → Overweight | Get Alert |
| 10/23/2017 | CELG | Buy Now | Celgene | — | — | Christopher Raymond60% | → $133 | Assumes | Overweight → Neutral | Get Alert |
| 10/23/2017 | BIIB | Buy Now | Biogen | $121.67 | 220.55% | Christopher Raymond60% | → $390 | Assumes | Overweight → Overweight | Get Alert |
| 09/21/2017 | BIIB | Buy Now | Biogen | $121.67 | — | Christopher Raymond60% | — | Downgrade | Strong Buy → Market Perform | Get Alert |
| 09/14/2017 | BMRN | Buy Now | Biomarin Pharmaceutical | $63.13 | — | Christopher Raymond60% | — | Assumes | Neutral → Overweight | Get Alert |
| 07/19/2017 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | — | Christopher Raymond60% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 11/07/2016 | BMRN | Buy Now | Biomarin Pharmaceutical | $63.13 | — | Christopher Raymond60% | — | Downgrade | Overweight → Neutral | Get Alert |
| 11/07/2016 | BIIB | Buy Now | Biogen | $121.67 | — | Christopher Raymond60% | — | Upgrade | Neutral → Overweight | Get Alert |
| 09/13/2016 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | — | Christopher Raymond60% | — | Initiates | → Market Perform | Get Alert |
| 11/05/2015 | BIIB | Buy Now | Biogen | $121.67 | — | Christopher Raymond60% | — | Upgrade | Neutral → Overweight | Get Alert |
| 11/05/2015 | AMGN | Buy Now | Amgen | $284.62 | — | Christopher Raymond60% | — | Upgrade | → Overweight | Get Alert |
| 08/04/2015 | BMRN | Buy Now | Biomarin Pharmaceutical | $63.13 | 166.12% | Christopher Raymond60% | $163 → $168 | Maintains | Overweight | Get Alert |
| 07/22/2015 | BIIB | Buy Now | Biogen | $121.67 | 236.99% | Christopher Raymond60% | $485 → $410 | Downgrade | Overweight → Neutral | Get Alert |
| 07/21/2015 | CELG | Buy Now | Celgene | — | — | Christopher Raymond60% | $147 → $160 | Maintains | Overweight | Get Alert |
| 06/18/2015 | BMRN | Buy Now | Biomarin Pharmaceutical | $63.13 | 132.85% | Christopher Raymond60% | $123 → $147 | Maintains | Overweight | Get Alert |
| 04/25/2014 | CELG | Buy Now | Celgene | — | — | Christopher Raymond60% | → $85 | Upgrade | Neutral → Overweight | Get Alert |
| 11/26/2013 | BMRN | Buy Now | Biomarin Pharmaceutical | $63.13 | — | Christopher Raymond60% | — | Assumes | → Overweight | Get Alert |
| 11/26/2013 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Christopher Raymond60% | — | Assumes | → Overweight | Get Alert |
| 11/26/2013 | BIIB | Buy Now | Biogen | $121.67 | — | Christopher Raymond60% | — | Assumes | → Overweight | Get Alert |
| 11/26/2013 | AMGN | Buy Now | Amgen | $284.62 | — | Christopher Raymond60% | — | Assumes | → Overweight | Get Alert |
| 11/26/2013 | CELG | Buy Now | Celgene | — | — | Christopher Raymond60% | — | Assumes | → Neutral | Get Alert |
| 08/26/2013 | AMGN | Buy Now | Amgen | $284.62 | -50.81% | Christopher Raymond60% | $120 → $140 | Upgrade | Neutral → Overweight | Get Alert |
| 04/24/2013 | AMGN | Buy Now | Amgen | $284.62 | -62.41% | Christopher Raymond60% | → $107 | Downgrade | Overweight → Neutral | Get Alert |
| 03/20/2013 | BMRN | Buy Now | Biomarin Pharmaceutical | $63.13 | 10.88% | Christopher Raymond60% | $64 → $70 | Maintains | Overweight | Get Alert |
| 02/25/2013 | AMGN | Buy Now | Amgen | $284.62 | -62.41% | Christopher Raymond60% | $104 → $107 | Maintains | Overweight | Get Alert |
| 02/19/2013 | BMRN | Buy Now | Biomarin Pharmaceutical | $63.13 | 1.38% | Christopher Raymond60% | $55 → $64 | Maintains | Overweight | Get Alert |
| 01/08/2013 | CELG | Buy Now | Celgene | — | — | Christopher Raymond60% | $43 → $55.5 | Upgrade | Neutral → Overweight | Get Alert |
| 01/03/2013 | BIIB | Buy Now | Biogen | $121.67 | 36.44% | Christopher Raymond60% | $175 → $166 | Downgrade | Overweight → Neutral | Get Alert |
| 10/18/2012 | BIIB | Buy Now | Biogen | $121.67 | 47.13% | Christopher Raymond60% | $159 → $179 | Maintains | Overweight | Get Alert |
| 07/27/2012 | AMGN | Buy Now | Amgen | $284.62 | -66.62% | Christopher Raymond60% | $77 → $95 | Upgrade | Neutral → Overweight | Get Alert |
| 06/05/2012 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Christopher Raymond60% | $108 → $110 | Maintains | Overweight | Get Alert |
| 05/01/2012 | BIIB | Buy Now | Biogen Idec | $121.67 | 30.69% | Christopher Raymond60% | $140 → $159 | Maintains | Overweight | Get Alert |
